Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yoshikazu Nagasaki is active.

Publication


Featured researches published by Yoshikazu Nagasaki.


Cancer | 1977

Clinicopathologic features of encapsulated hepatocellular carcinoma. A study of 26 cases

Kunio Okuda; Hirotaka Musha; Yukio Nakajima; Yasuhiko Kubo; Yutaka Shimokawa; Yoshikazu Nagasaki; Yasuhiko Sawa; Shigenobu Jinnouchi; Toshioki Kaneko; Hiroshi Obata; Toju Hisamitsu; Yoji Motoike; Nobuo Okazaki; Masamichi Kojiro; Kazuyoshi Sakamoto; Toshiro Nakashima

The clinicopathologic features of 26 cases of hepatocellular carcinoma (HCC) surrounded by a grossly distinct capsule‐like fibrous tissue were studied. The frequency of this type was 10.3% among autopsy cases of HCC. The mean age of the patients was 64.1 years, which was significantly older compared with that of 143 cases of nonencapsulated HCC. Hepatitis‐B surface antigen in serum was positive in 18.7% of the cases studied, the positivity rate being lower than that of HCC in general. Histologically, the tumor was relatively well differentiated and the capsule was the product of slow expanding growth. Intravenous tumor invasion was less frequent compared with other types of HCC. Clinically, celiac angiography proves to be a most useful diagnostic method; a thick capsule may be demonstrated as a thin radiolucent rim around the mass. The clinical course from the early stage is protracted and, if detected early, this type of HCC may be removed surgically.


Radiology | 1977

Angiographic demonstration of intrahepatic arterio-portal anastomoses in hepatocellular carcinoma.

Kunio Okuda; Hirotaka Musha; Takeshi Yamasaki; Shigenobu Jinnouchi; Yoshikazu Nagasaki; Yasuhiko Kubo; Yutaka Shimokawa; Toshimichi Nakayama; Masamichi Kojiro; Kazuyoshi Sakamoto; Toshiro Nakashima

Hepatic angiograms of 114 patients with hepatocellular carcinoma (HCC) were studied, particularly changes in the portal vein branches. Arterio-portal shunts of varying sizes, evidenced by opacification of intrahepatic portal branches, were seen in 72 cases (63.2%), with retrograde opacification of the portal vein trunk in 29 (25.4%). At least four types of shunts were found: (a) through a tumor thrombus in the portal branch, (b) in a retrograde direction via a peripheral tumor nodule, (c) through a small tumor invading or amputating an artery, and (d) through a tumor located near a major portal vein branch and supplied by a large, coiling artery. Postmortem angiography of the liver in 50 patients with HCC suggests that arterio-portal shunts are the result of the special vasculature in HCC and are highly diagnostic when accompanied by other angiographic changes.


Radiology | 1977

Angiographic Assessment of Gross Anatomy of Hepatocellular Carcinoma: Comparison of Celiac Angiograms and Liver Pathology in 100 Cases1

Kunio Okuda; Hiroshi Obata; Shigenobu Jinnouchi; Yasuhiko Kubo; Yoshikazu Nagasaki; Yutaka Shimokawa; Yoji Motoike; Haruomi Muto; Yukio Nakajima; Hirotaka Musha; Takeshi Yamazaki; Kazuyoshi Sakamoto; Masamichi Kojiro; Toshiro Nakashima

Of 190 sets selective celiac and/or hepatic angiograms obtained in patients with hepatocellular carcinoma (HCC), comparison with gross anatomy of the liver was subsequently made by autopsy in 77 and by surgery in 23. It was found that the gross anatomy of HCC can be assessed with certain accuracy by careful interpretation of the angiograms, because tumor vasculature and vascular alterations in the noncancerous parenchyma are closely related to the mode of tumor growth, size of tumor nodules and their distribution. Even a fibrous capsule of the tumor may be discerned as a radiolucent zone around the tumor contour. Diagnosis of the gross anatomical type of HCC is important to the selection of therapeutic measure and assessment of prognosis.


Gastroenterology | 1977

Antibody To Hepatitis B Core Antigen In Patients With Hepatocellular Carcinoma

Yasuhiko Kubo; Kunio Okuda; Masaharu Hashimoto; Yoshikazu Nagasaki; Hiroyuki Ebata; Yukio Nakajima; Hirotaka Musha; Koshi Sakuma; Hachiro Ohtake

Hepatitis B surface antigen (HBsAg), anti-HBs, and anti-HB core (HBc) were measured in 124 patients with hepatocellular carcinoma (HCC) in comparison with 299 control subjects of comparable ages, and in 48 cases of chronic hepatitis and 52 cases of hepatic cirrhosis. It was found that 72.6% of the HCC patients were positive for anti-HBc, and 80.6% were positive for at least one test, whereas in the control, anti-HBc was positive in 30.1% and 34.1% were positive for at least one test, the differences between the two groups being significant (P less than 0.01). The frequencies of positive tests for HBsAg and anti-HBc were the highest in HCC followed in decreasing order by cirrhosis, chronic hepatitis and the control group. A possible role of HB virus infection in hepatocellular carcinoma is discussed in relation to other factors.


Cancer | 1977

Serum glutamic oxalacetic transaminase/glutamic pyruvic transaminase ratios in hepatocellular carcinoma.

Yutaka Shimokawa; Kunio Okuda; Yasuhiko Kubo; Akira Kaneko; Tsuneaki Arishima; Eisuke Nagata; Masaharu Hashimoto; Yasuhiko Sawa; Yoshikazu Nagasaki; Masamichi Kojiro; Kazuyoshi Sakamoto; Toshiro Nakashima

Serum enzyme activities were studied in 131 cases of hepatocellular carcinoma (HCC), 76 cases of metastatic liver carcinomas (MLC) and 234 cases of hepatic cirrhosis. SGOT was elevated above SGPT in most of the time in these patients, SGOT/SGPT was greater in HCC compared with other groups, and that this ratio increased during the preterminal period more markedly in patients with HCC because of the significant increase of SGOT in the face of relatively stable SGPT. Preterminal rises of alkaline phosphatase and LDH activities were more pronounced in MLC. Leucine aminopeptidase activity exhibited no characteristic feature of diagnostic value. Of the five enzymes, SGOT changes were more closely correlated with the growth of HCC; SGPT reflected more of the liver parenchymal damage while SGOT was probably accounted for in part by tumor‐derived GOT. Other clinical and pathological implications are discussed. Cancer 40:319–324, 1977.


Digestive Endoscopy | 1994

A New Assessment of Esophageal Varices by Endoscopic Ultrasonography Using a 15/20-Megahertz Ultrasonic Probe

Masatoshi Nishizono; Junichiro Sakata; Tsuyoshi Ohashi; Yasuaki Haraguchi; Tanenao Eto; Hideki Kamikawa; Fumitoshi Bekki; Yoshikazu Nagasaki; Nobuhiko Koga; Toshihiko Koga; Yuichi Yamashita

Abstract: We examined esophageal varices using the new technique of endoscopic ultrasonography (EUS) that employed a high‐resolution 15/20 MHz ultrasonic probe. EUS employing the direct contact method, in which the forceps‐channel probe was in direct contact with the lumen, was used in patients with esophageal varices (58 cases) and in control patients without varices (32 cases). Findings were also compared with additional EUS employing the conventional balloon method which was performed on 21 of the patients with esophageal varices.


Kanzo | 1979

Studies on Arterio-Portal Vein Shunt Demonstrated by Celiac Angiography in Hepatocellular Carcinoma

Yoshikazu Nagasaki

肝細胞癌154例に腹腔動脈造影を行い,87例(56%)に門脈内腫瘍塞栓の存在を示す所見である動門脈吻合(A-V shunt)を認めた.1次分枝以上の門脈枝の出現(Type II)は51例(33%)で,逆行性の流れが見られた.2次分枝以下の門脈枝の出現(Type I)は36例(23%)で,順行性の流れであった.食道・胃静脈瘤の頻度は,Type IIのA-V shunt群78.9%とA-V shuntを認めない群50.9%に有意の差が見られた.自覚症状発現時および化学療法開始からの生存期間は,Type II群はA-V shuntを認めない群に比べ,有意に短かった.


Radiology | 1977

Angiographic demonstration of growth of hepatocellular carcinoma in the hepatic vein and inferior vena cava.

Kunio Okuda; Shigenobu Jinnouchi; Yoshikazu Nagasaki; Seido Kuwahara; Toshioki Kaneko; Yasuhiko Kubo; Yutaka Shimokawa; Yukio Nakajima; Motohide Takashi; Hirotaka Musha; Takahiro Kudo; Kazuyoshi Sakamoto; Masamichi Kojiro; Toshiro Nakashima


Kanzo | 1976

Studies on Primary Liver Carcinoma. III.

Shigenobu Jinnouchi; Yasuhiko Kubo; Yutaka Shimokawa; Mikio Moriyama; Seido Kuwahara; Yoshikazu Nagasaki; Kazuyoshi Sakamoo; Toshiro Nakashima; Takeshi Yamazaki; Yukio Nakajima; Kunio Okuda


Kanzo | 1987

Evaluation of ultrasonically-guided percutaneous ethanol injection to the hepatocellular carcinoma.

Yuichi Yamashita; Kazuyoshi Sakamoto; Toshihiko Kurohiji; Hiroharu Isomoto; Teruo Kakegawa; Masanori Noutomi; Hiromichi Sumino; Yoshikazu Nagasaki

Collaboration


Dive into the Yoshikazu Nagasaki's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge